Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 ,inter alia, to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results for the Fourth quarter and Year ended March 31, 2024 2. To consider other business matters along with Recommendation of Dividend, if any. 3. Any other Business Further, in continuation of our earlier letter dated April 01, 2024 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative, the trading window for dealing in the securities of the Company shall remain closed up to 48 hours after the declaration of the Financial Results of the Company for the fourth quarter and Financial Year ended March 31, 2024. You are requested to take the same on record.